首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1410180

先進傷口護理市場：2023年至2028年預測

Advanced Wound Care Market - Forecasts from 2023 to 2028

出版日期: 2023年12月13日 | 出版商:

Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

高級傷口護理市場預計在預測期內將以 4.52% 的複合年成長率成長，到 2028 年市場規模將從 2021 年的 31.33 億美元達到 42.7 億美元。

高級傷口護理是指治療困難的慢性傷口。與標準傷口敷料相比，先進的傷口護理由新型材料和治療方法組成，可促進更快、更有效的創傷治療。人口老化、糖尿病和肥胖等慢性病的盛行率不斷上升，以及對複雜傷口護理方法的了解不斷增加，正在推動這一市場的擴張。透過水分管理、組織再生和感染控制促進創傷治療、傷口護理設備和生物活性材料是先進傷口護理解決方案的例子。隨著醫療保健專業人員和患者尋求更好的創傷治療癒合，先進的傷口護理市場繼續顯著成長並在研發方面投入資金。

慢性傷口的增加推動先進傷口護理市場的成長

由於全球慢性傷口盛行率不斷上升，先進傷口護理市場正在擴大。根據世界衛生組織的研究，糖尿病足潰瘍、壓瘡和腿部靜脈潰瘍等慢性傷口影響數百萬人，並導致巨大的醫療費用。糖尿病的流行、人口老化和生活方式的改變都會導致慢性傷口的增加。因此，醫療從業人員和患者需要更多的傷口護理解決方案，以實現更快、更有效的癒合，從而刺激了對新型傷口敷料、生物活性材料和傷口護理設備的需求。這一趨勢正在推動先進傷口護理市場的成長，以滿足對更好傷口護理的迫切需求。

糖尿病和肥胖症盛行率的增加正在推動先進傷口護理市場的成長。

由於全球糖尿病和肥胖症盛行率不斷上升，先進的傷口護理市場正在擴大。根據國際糖尿病聯盟的數據，2019 年約有 4.63 億人患有糖尿病，預計到 2045 年將增加至 7 億。糖尿病和肥胖是慢性潰瘍的主要危險因素，包括糖尿病足潰瘍和壓瘡。隨著這些疾病的惡化，對先進傷口護理產品和治療方法的需求不斷成長，以解決糖尿病和肥胖患者傷口管理的獨特挑戰。醫療保健專業人員正在尋求新的傷口敷料和生物活性解決方案，以促進這些脆弱患者的癒合並預防問題，這正在推動市場擴張。

生物活性傷口護理產品的技術創新正在推動先進傷口護理市場的成長。

生物活性傷口護理產品的技術進步透過提供有效的傷口護理選擇徹底改變了先進傷口護理市場。生物活性傷口護理方案與傷口環境相互作用並刺激組織再生。這些突破性產品包括先進敷料、生長激素和皮膚替代品。這些技術透過創造濕潤、有利的環境、降低感染風險並促進組織恢復來改善創傷治療。生物活性傷口護理解決方案的開發為醫療保健臨床醫生和患者提供了多種選擇，以更有效地治療複雜傷口、慢性潰瘍和燒傷。隨著該領域研究和開發的進步，市場可能會穩步擴大，改善患者的治療效果並提供更高品質的傷口護理。

北美是先進傷口護理市場的領導者。

北美主導先進傷口護理市場。完善的衛生治療系統、大量的慢性傷口患者以及人口老化支撐了該地區的優勢。此外，大量的研發工作、技術改進和不斷上漲的醫療成本也促進了北美先進傷口護理市場的成長。此外，重要市場參與企業的存在以及對新穎性傷口護理產品和治療方法的關注也有助於該地區在該行業的領導地位。北美地區糖尿病和肥胖症等慢性病的盛行率不斷上升，增加了對先進傷口護理的需求。

對更快、更有效的創傷治療的日益關注將推動先進傷口護理市場的規模。

由於人們對更快、更有效的創傷治療越來越感興趣，先進的傷口護理市場正在不斷擴大。健康從業者和患者正在尋求新穎的傷口護理解決方案，以加速創傷治療並改善患者的治療結果。加速創傷治療正在引起人們的關注，其目的是縮短住院時間、降低醫療費用並提高患者的生活品質。為了滿足這項需求，正在開發先進的傷口敷料、生長因子和生物活性產品，為組織再生提供有利的環境，同時降低感染風險。隨著對快速有效的創傷治療的需求越來越廣泛地認知到，市場將繼續成長以滿足這種不斷變化的需求。

主要進展

2023年7月，全球醫療科技公司Smith + Nephew宣佈在印度推出REGENETEN生物感應植入物。 REGENETEN 植入物極大地影響了外科醫生進行肩迴旋肌手術的方式，自推出以來，全球已實施了超過 100,000 例手術。基於膠原蛋白的 REGENETEN 生物感應植入物可促進新肌腱樣組織的形成1-3,6，生理上補充現有肌腱並逆轉疾病進展。 2023 年7 月，專門從事慢性病管理的富時100 強全球醫療產品和技術公司Convatec Group Plc 宣布推出用於Tandem Diabetes Care 的新型5 英寸輸液器和Tandem Mobi，這是世界上最小的耐用自動胰島素輸送系統。我們宣布就一套產品進行合作，並於最近獲得 FDA 510(k) 批准。 Convatec 是輸液技術以及胰島素幫浦插入設備設計和製造的全球領導者。

公司產品

傷口敷料：泡棉敷料、親水膠體敷料和矽膠敷料是全錄輝提供的先進傷口敷料。這些敷料旨在透過創造濕潤的創傷治療環境來促進創傷治療。
手術切口管理： Smith & Nephew 銷售切口管理產品，包括黏合敷料和固定裝置，以幫助傷口護理。
親水膠體敷料Molnlycke 提供有助於自溶解清創和創傷治療的親水膠體膠體敷料。
矽膠敷料Molnlycke 提供矽膠傷口敷料。它對皮膚溫和，能很好地黏附在傷口表面的凹凸處。
親水性纖維敷料敷料： ConvaTec 提供親水性纖維敷料敷料，可吸收和密封多餘的傷口滲出物，保持濕潤的創傷治療環境並改善創傷治療。

The advanced wound care refers to the treatment of difficult and chronic wounds. When compared to standard wound dressings, advanced wound care comprises novel materials and therapies that promote quicker and more efficient wound healing. The expansion of this market is being driven by factors such as an ageing population, an increase in the incidence of chronic conditions such as diabetes and obesity, and increased knowledge of sophisticated wound care therapies. Dressings, wound treatment devices, and bioactive materials that promote wound healing through moisture management, tissue regeneration, and infection control are examples of advanced wound care solutions. As healthcare practitioners and patients seek better wound healing results, the advanced wound care market continues to experience substantial developments and R&D expenditures.

Increasing Incidence of Chronic Wounds drives the Advanced Wound Care Market growth.

The advanced wound care market is expanding due to the rising prevalence of chronic wounds worldwide. According to World Health Organisation research, chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers afflict millions of individuals, resulting in enormous healthcare costs. Diabetes prevalence, ageing populations, and lifestyle variables all lead to an increase in chronic wound cases. As a result, healthcare practitioners and patients are increasingly looking for enhanced wound care solutions that deliver quicker and more effective healing, fuelling demand for novel wound dressings, bioactive materials, and wound treatment devices. This trend is driving the growth of the advanced wound care market in order to meet the urgent demand for better wound treatment.

Growing Prevalence of Diabetes and Obesity Enhances the Advanced Wound Care Market Growth.

Because of the rising prevalence of diabetes and obesity worldwide, the advanced wound care market is expanding. According to the International Diabetes Federation, around 463 million individuals in 2019 had diabetes, with this figure expected to rise to 700 million by 2045. Diabetes and obesity are major risk factors for chronic sores including diabetic foot ulcers and pressure ulcers. As these illnesses worsen, there is a greater need for sophisticated wound care products and therapies that address the particular issues of wound management in diabetic and obese patients. Healthcare professionals are looking for novel wound dressings and bioactive solutions to enhance healing results and prevent problems in this vulnerable group, which is driving market expansion.

Technological Innovations in Bioactive Wound Care Products drive the Advanced Wound Care Market Growth.

Technological advancements in bioactive wound care products have revolutionised the advanced wound care market by giving efficient wound healing options. Bioactive wound care solutions interact with the wound environment to stimulate tissue regeneration. These revolutionary items include advanced dressings, growth hormones, and skin replacements. These technologies improve wound healing by creating a moist and favourable environment, lowering the risk of infection, and expediting tissue restoration. The development of bioactive wound care solutions provides healthcare clinicians and patients with a variety of choices for more effectively treating complicated wounds, chronic ulcers, and burns. As research and development in this discipline progresses, the market is likely to increase steadily, providing better patient outcomes and higher quality wound care.

North America is the Market Leader in the Advanced Wound Care Market.

North America dominates the advanced wound care market. A well-established healthcare system, a huge patient pool with chronic wounds, and an ageing population all contribute to the region's dominance. Furthermore, substantial R&D efforts, technical improvements, and increased healthcare expenditure all contribute to the advanced wound care market's growth in North America. Furthermore, the presence of important market participants, as well as a strong emphasis on novel wound care products and therapies, contribute to the region's leadership in this industry. The rising incidence of chronic illnesses including diabetes and obesity fuels demand for sophisticated wound care treatments in North America.

Growing Focus on Faster and Effective Wound Healing Bolsters the Advanced Wound Care Market Size.

The advanced wound care market is expanding due to a growing emphasis on quicker and more efficient wound healing. Healthcare practitioners and patients are looking for novel wound care solutions that help speed up healing and improve patient outcomes. The goal to shorten hospital stays, lower healthcare costs, and enhance patients' quality of life is driving the focus on speedier wound healing. To meet this need, advanced wound dressings, growth factors, and bioactive products are being developed, providing a favourable environment for tissue regeneration while reducing the risk of infection. As the need for speedy and effective wound healing becomes more widely recognised, the market is positioned for continued growth to satisfy these changing demands.

Key Developments:

In July 2023, The worldwide medical technology company Smith+Nephew has announced the introduction of their REGENETEN Bioinductive Implant in India. The REGENETEN implant has had a dramatic influence on the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN Bioinductive Implant facilitates the creation of new tendon-like tissue1-3,6 to physiologically supplement the existing tendon and reverse the course of disease progression.
In July 2023, Convatec Group Plc, an FTSE 100 global medical products and technologies company focused on chronic condition management announced a collaboration with Tandem Diabetes Care on a new five-inch infusion set for Tandem Mobi, the world's smallest durable automated insulin delivery system, which has now received FDA 510(k) clearance. Convatec is the global leader in the design and manufacture of infusion technology and insulin pump insertion devices.

Company Products:

Wound Dressings: Foam dressings, hydrocolloid dressings, and silicone dressings are among the advanced wound dressings available from Smith & Nephew. These dressings are intended to enhance successful wound healing by creating a moist wound-healing environment.
Surgical Incision Management: The firm sells surgical incision management items such as sticky dressings and securement devices to help with post-operative wound care.
Hydrocolloid Dressings: Molnlycke offers hydrocolloid dressings that aid in autolytic debridement and wound healing.
Silicone Dressings: Molnlycke provides silicone-based wound dressings that are soft on the skin and cling well to uneven wound surfaces.
Hydrofiber Dressings: ConvaTec provides hydrofiber dressings that absorb and seal away excess wound exudate, maintaining a moist wound-healing environment and improving wound healing.

Segmentation:

By Product Type

Dressings
Foam Dressings
Hydrocolloid Dressings
Alginate Dressings
Film Dressings
Hydrogel Dressings
Collagen Dressings
Others
Wound Therapy Devices
Negative Pressure Wound Therapy (Npwt) Devices
Oxygen And Hyperbaric Oxygen Equipment
Electrical Stimulation Devices
Ultrasound Therapy Devices
Others

By Wound Type

Diabetic Ulcers
Pressure Ulcers
Venous Ulcers
Surgical Wounds
Burns
Others

By End-User

Hospitals And Clinics
Home Care Settings
Long-Term Care Centers
Ambulatory Surgical Centers
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Taiwan
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Sources
2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4.. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

5.1. Introduction
5.2. DRESSINGS
- 5.2.1. FOAM DRESSINGS
- 5.2.2. HYDROCOLLOID DRESSINGS
- 5.2.3. ALGINATE DRESSINGS
- 5.2.4. FILM DRESSINGS
- 5.2.5. HYDROGEL DRESSINGS
- 5.2.6. COLLAGEN DRESSINGS
- 5.2.7. OTHERS
5.3. WOUND THERAPY DEVICES
- 5.3.1. NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
- 5.3.2. OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT
- 5.3.3. ELECTRICAL STIMULATION DEVICES
- 5.3.4. ULTRASOUND THERAPY DEVICES
- 5.3.5. OTHERS

6. ADVANCED WOUND CARE MARKET, BY WOUND TYPE

6.1. Introduction
6.2. DIABETIC ULCERS
6.3. PRESSURE ULCERS
6.4. VENOUS ULCERS
6.5. SURGICAL WOUNDS
6.6. BURNS
6.7. OTHERS

7. ADVANCED WOUND CARE MARKET, BY END-USER

7.1. Introduction
7.2. HOSPITALS AND CLINICS
7.3. HOME CARE SETTINGS
7.4. LONG-TERM CARE CENTERS
7.5. AMBULATORY SURGICAL CENTERS
7.6. OTHERS

8. ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Taiwan
- 8.6.7. Others